EGFR and non-small cell lung carcinoma: P53 would also make chemically resistant non-small cell lung cancer sensitive by increasing the reactive oxygen species and inhibiting EGFR/PI3K/AKT signal.[38] Moreover, in advanced NSCLC, p53 mutations are strongly associated with immune checkpoint inhibitor response and longer survival.[39]